NH Investment & Securities Co., Ltd. (005940.KS)
KSE - KSE Delayed Price. Currency in KRW
Add to watchlist
At close: 03:30PM KST
| Previous Close | 11,910.00 |
| Open | 11,990.00 |
| Bid | 12,300.00 x 0 |
| Ask | 12,310.00 x 0 |
| Day's Range | 11,880.00 - 12,370.00 |
| 52 Week Range | 9,060.00 - 13,100.00 |
| Volume | |
| Avg. Volume | 918,754 |
| Market Cap | 4.238T |
| Beta (5Y Monthly) | 0.61 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Jul 25, 2024 - Jul 29, 2024 |
| Forward Dividend & Yield | 800.00 (6.72%) |
| Ex-Dividend Date | Mar 28, 2024 |
| 1y Target Est | 13,667.00 |
PR NewswireUNLIMEAT Pulled Pork Wrap Now Available at All Starbucks Stores in HK
UNLIMEAT announced on the 16th the launch of its Pulled Pork Wrap at Starbucks stores throughout Hong Kong. The UNLIMEAT Pulled Pork Wrap is a fully plant-based product containing UNLIMEAT's pulled pork, along with refreshing carrot, vibrant red cabbage, and crisp lettuce, all wrapped together for a satisfying and guilt-free meal.
PR NewswireImmunoForge Doses First Patient in Phase 2 Clinical Trial of Froniglutide for Dermatomyositis/Polymyositis
ImmunoForge today announced that it has dosed the first patient in its Phase 2 clinical trial to evaluate the efficacy, safety, and pharmacokinetic properties of Froniglutide in patients with dermatomyositis/polymyositis.
© 2024 Yahoo. All rights reserved.